BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Höflich A, Kraus C, Pfeiffer RM, Seiger R, Rujescu D, Zarate CA Jr, Kasper S, Winkler D, Lanzenberger R. Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial. Transl Psychiatry 2021;11:200. [PMID: 33795646 DOI: 10.1038/s41398-021-01318-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilkowska A, Cubała WJ. The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine. IJMS 2022;23:14605. [DOI: 10.3390/ijms232314605] [Reference Citation Analysis]
2 Wei W, Zhang A, Liu L, Zheng X, Tang C, Zhou M, Gu Y, Yao Y. Effects of subanaesthetic S-ketamine on postoperative delirium and cognitive function in elderly patients undergoing non-cardiac thoracic surgery: a protocol for a randomised, double-blinded, placebo-controlled and positive-controlled, non-inferiority trial (SKED trial). BMJ Open 2022;12:e061535. [PMID: 35914911 DOI: 10.1136/bmjopen-2022-061535] [Reference Citation Analysis]
3 Hou L, Miao J, Meng H, Liu X, Wang D, Tan Y, Li C. Sirtuin Type 1 Mediates the Antidepressant Effect of S-Ketamine in a Chronic Unpredictable Stress Model. Front Psychiatry 2022;13:855810. [DOI: 10.3389/fpsyt.2022.855810] [Reference Citation Analysis]
4 Vanicek T, Unterholzner J, Lanzenberger R, Naderi-heiden A, Kasper S, Praschak-rieder N. Intravenous Esketamine Leads to an Increase in Impulsive and Suicidal Behavior in a Patient with Recurrent Major Depression and Borderline Personality Disorder. The World Journal of Biological Psychiatry. [DOI: 10.1080/15622975.2022.2031287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kojic M, Saelens J, Kadriu B, Zarate CA, Kraus C. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics. Disruptive Psychopharmacology 2022. [DOI: 10.1007/7854_2022_313] [Reference Citation Analysis]
6 Hess EM, Riggs LM, Michaelides M, Gould TD. Mechanisms of Ketamine and its Metabolites as Antidepressants. Biochem Pharmacol 2021;:114892. [PMID: 34968492 DOI: 10.1016/j.bcp.2021.114892] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
7 Suzuki K, Kim JW, Nosyreva E, Kavalali ET, Monteggia LM. Convergence of distinct signaling pathways on synaptic scaling to trigger rapid antidepressant action. Cell Rep 2021;37:109918. [PMID: 34731624 DOI: 10.1016/j.celrep.2021.109918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]